Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
---|
06/21/1994 | US5322837 Stimulating production of red blood cells |
06/21/1994 | US5322836 Bioactive agents, compositions and materials comprising said bioactive agents |
06/21/1994 | US5322801 Protein partner screening assays and uses thereof |
06/21/1994 | US5322795 HPLC assay for the selective resolution of recombinant proteins |
06/21/1994 | US5322787 Using SPGM-1 cell line, testing for maintenance, proliferation |
06/21/1994 | US5322784 Transforming Escherichia coli with shuttle vector comprising mobilization regions permitting transfer to colonic species of Bacteroides and then to Prevotella and heterologous DNA operatively linked to functional promoter |
06/21/1994 | US5322774 Procaryotic leader sequence in recombinant baculovirus expression system |
06/21/1994 | US5322772 Competitive protein binding |
06/21/1994 | US5322769 Methods for using CKS fusion proteins |
06/21/1994 | US5322699 Leukocyte-derived CR3 modulator, integrin modulating factor-1 (IMF-1) |
06/21/1994 | US5322687 Bacillus thuringiensis cryet4 and cryet5 toxin genes and proteins toxic to lepidopteran insects |
06/21/1994 | US5322678 Alteration of pharmacokinetics of proteins by charge modification |
06/21/1994 | CA1330302C Concentrates of coagulation factors ii, vii, ix and x, method of their preparation and use |
06/18/1994 | CA2111603A1 Stable antibody solution and stabilization of antibody |
06/17/1994 | CA2111656A1 Variants of corticosteroid binding globulin |
06/17/1994 | CA2085924A1 Putative therapeutic targets for the prevention and stoppage of human alzheimer's disease: cdna and amino acid sequence of a proteinase/esterase-like protein and a proteinase/protamine, truncated, modified form of the protein, anti ense to the alzheimer elated human app gene |
06/16/1994 | DE4322570C1 Stromal cell lines from human bone marrow cells - contain SV-40 DNA with defective origin of replication, useful as feeder cells, for prodn. of growth factors and for gene expression |
06/16/1994 | CA2111321A1 Process for the production of polypeptides |
06/15/1994 | EP0602004A1 Peptides having T cell helper activity |
06/15/1994 | EP0602003A1 Peptides having T cell helper activity |
06/15/1994 | EP0601979A2 Exogenous antigens bound to hepatitis B virus envelope antigen |
06/15/1994 | EP0601834A1 Method of cleaving a nucleic acid molecule |
06/15/1994 | EP0601360A1 Progenitor B cell stimulating factor |
06/15/1994 | EP0601318A2 Process for production of a conjugate from a specific binding partner and a carbohydrate containing protein |
06/15/1994 | EP0601183A1 Anti-hiv drug |
06/15/1994 | EP0601135A1 Osteogenic proteins in the treatment of bone diseases |
06/15/1994 | EP0601129A1 Morphogenic protein screening method |
06/15/1994 | EP0601125A1 V$g(a)12.1 T-CELL RECEPTOR-SPECIFIC REAGENTS FOR DIAGNOSING AND TREATING RHEUMATOID ARTHRITIS |
06/15/1994 | EP0601108A1 Multideterminant peptide antigens that stimulate helper t lymphocyte response to hiv in a range of human subjects |
06/15/1994 | EP0601106A1 Morphogen-induced modulation of inflammatory response |
06/15/1994 | EP0601043A1 Hybrid cytokines |
06/15/1994 | EP0600993A1 Proteins with insecticidal properties against homopteran insects and their use in plant protection |
06/15/1994 | EP0600992A1 Use of gentisic acid or gentisyl alcohol for stabilising radiolabeled peptides and proteins |
06/15/1994 | EP0600970A1 Use of interleukin-10 analogs or antagonists to treat endotoxin- or superantigen induced toxicity |
06/15/1994 | EP0600930A1 Diagnosis and treatment of autoimmune diseases |
06/15/1994 | EP0600884A1 PROTECTIVE FOUR AMINO ACID EPITOPE AGAINST $i(PLASMODIUM VIVAX) MALARIA |
06/15/1994 | EP0600880A1 INTERLEUKIN 1$g(b) PROTEASE AND INTERLEUKIN 1$g(b) PROTEASE INHIBITORS |
06/15/1994 | EP0600875A1 Purification of recombinant apolipoprotein e from bacteria |
06/15/1994 | EP0600869A1 Synthetic peptides for arterial imaging |
06/15/1994 | EP0600866A1 Compositions and methods for identifying biologically active molecules |
06/15/1994 | EP0469045B1 SYNTHETIC $i(PSEUDOMONAS) $i(AERUGINOSA) PILIN PEPTIDE AND RELATED VACCINES AND DIAGNOSTICS |
06/15/1994 | EP0469017B1 Expression of human apolipoproteins ai-milano in yeast |
06/15/1994 | EP0441832B1 Composition and treatment with biologically active peptides and certain anions |
06/15/1994 | EP0401379B1 STABILIZED COMPOSITION OF INTERLEUKIN-1$g(b) |
06/15/1994 | EP0391972B1 Cucumber mosaic virus coat protein gene |
06/15/1994 | EP0374178B1 Process for preparing veterinary acellular vaccines against gram-negative nonenteric pathogenic bacilli |
06/15/1994 | CN1087916A Glycosilated cytokines |
06/15/1994 | CN1087915A Antigenic peptides for grouping hepatitis C virus, kit comprising the same and methods for its grouping using the same |
06/15/1994 | CN1087914A Purification of white protein |
06/15/1994 | CA2110854A1 Antiviral antibiotic bu-4628v and preparation thereof |
06/15/1994 | CA2110827A1 Antiviral antibiotic bu-4724v and preparation thereof |
06/14/1994 | US5321142 Compounds from biopolymers and effector substances which are linked via optically active amino acid derivatives, processes for the preparation thereof and the use thereof |
06/14/1994 | US5321127 Antiplatelet and antithrombotic activity of platelet glycoprotein Ib receptor fragments |
06/14/1994 | US5321126 Method of preparing a fibrinogen concentrate from blood plasma |
06/14/1994 | US5321124 Art (rev) protein of human T-cell leukemia virus |
06/14/1994 | US5321123 Protein S polypeptides and anti-peptide antibodies that inhibit protein S binding to C4B binding protein, diagnostic systems and therapeutic methods |
06/14/1994 | US5321030 Administering for treatment or prevention |
06/14/1994 | US5321010 Proteins for inhibiting adhesion of platelets to collagen |
06/14/1994 | US5320970 Detection of collagen degradation in vivo |
06/14/1994 | US5320962 DNA encoding the human A1 adenosine receptor |
06/14/1994 | US5320958 Isolated bacterial reverse transcriptase |
06/14/1994 | US5320953 Incubating microorganism transformed by expression vector comprising DNA sequence coding for human prorelaxin, purifying |
06/14/1994 | US5320952 Cells transformed with dna sequences; genetic engineering |
06/14/1994 | US5320951 Fibronectin binding protein as well as its preparation |
06/14/1994 | US5320950 DNA encoding anticoagulative protein PP4-X, and its preparation and use |
06/14/1994 | US5320947 Immune reactivity to expressed activated oncogenes for diagnosis of malignancy |
06/14/1994 | US5320942 Detecting pancreatic cells |
06/14/1994 | US5320941 DNA sequence encoding mas onhcogene, polypeptides encoded therefrom and diagnostic and other methods based therefrom |
06/14/1994 | US5320840 Continuous release pharmaceutical compositions |
06/12/1994 | CA2110934A1 Human cns receptors of the nmda-r1 family |
06/12/1994 | CA2110672A1 Spiro peperidines and holologs which promote release of growth hormone |
06/10/1994 | CA2110543A1 Peg hydrazone and peg oxime linkage forming reagents and protein derivatives thereof |
06/09/1994 | WO1994012880A2 Rxr homodimer formation and bridged bicyclic aromatic compounds and their use in modulating gene expression |
06/09/1994 | WO1994012668A1 Mammalian muscle nad:arginine adp-ribosyltransferase |
06/09/1994 | WO1994012666A1 Method of promoting intermolecular interactions involving a nucleic acid and molecules useful therefor |
06/09/1994 | WO1994012661A1 Anti-feline herpesvirus-1 recombinant antibody and gene fragment coding for said antibody |
06/09/1994 | WO1994012659A1 Preventing endogenous aminopeptidase mediated n-terminal amino acid cleavage during expression of foreign genes in bacteria |
06/09/1994 | WO1994012650A2 Activating expression of an amplifying endogenous gene by homologous recombination |
06/09/1994 | WO1994012649A2 Gene therapy for cystic fibrosis |
06/09/1994 | WO1994012648A2 Method for producing soluble t-receptors by co-transfection, and use of resulting products |
06/09/1994 | WO1994012642A1 Bacillus thuringiensis isolates active against lepidopteran pests |
06/09/1994 | WO1994012641A1 Haemophilus outer membrane protein |
06/09/1994 | WO1994012640A1 RECOMBINANT NUCLEIC ACID, POLYPEPTIDE MATERIAL CODED THEREBY AND TRANSMISSION BLOCKING VACCINE BASED THEREON FOR CONTROLLING THE MALARIA PARASITE $i(PLASMODIUM FALCIPARUM ) |
06/09/1994 | WO1994012639A2 Interleukin-3 (il-3) mutant polypeptides |
06/09/1994 | WO1994012638A2 Interleukin-3 (il-3) multiple mutation polypeptides |
06/09/1994 | WO1994012637A2 Novel human amyloid protein precursor homologue and kunitz-type inhibitors |
06/09/1994 | WO1994012636A1 Method of controlling polypeptide production in bacteria |
06/09/1994 | WO1994012635A2 Novel seven transmembrane receptors |
06/09/1994 | WO1994012634A1 Neurotrophic factor |
06/09/1994 | WO1994012631A1 Peptide corresponding to cd44 exon 6, antibodies specific for said peptide and use of these antibodies for diagnosis of tumors |
06/09/1994 | WO1994012630A2 Method for producing polypeptide via bacterial fermentation |
06/09/1994 | WO1994012628A1 Cloning and expression of biologically active alpha-galactosidase a |
06/09/1994 | WO1994012627A1 Transgenic animal model for alzheimer's disease |
06/09/1994 | WO1994012626A1 Cell-type specific gene transfer using retroviral vectors containing antibody-envelope fusion proteins |
06/09/1994 | WO1994012617A1 Hepatitis b virus vaccines |
06/09/1994 | WO1994012616A1 Human pituitary cell lines |
06/09/1994 | WO1994012615A1 Mycoplasma diagnostic assay |
06/09/1994 | WO1994012539A1 Multifunctional neurotrophic factors |
06/09/1994 | WO1994012537A2 Granulocyte chemotactic protein |
06/09/1994 | WO1994012535A1 Progenitor b cell stimulating factor |